ADIM
TMO icon

Alpha DNA Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Alpha DNA Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-48
Closed -$22K – 777
2020
Q4 		$22K Buy
+48
New +$22.5K 0.02% 254

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's TMO Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Thermo Fisher Scientific (TMO) in Q1 2021, closing a stake of 48 shares — an estimated $22K sold.

Alpha DNA Investment Management first reported a position in TMO in Q4 2020 and held it in 1 quarter. The position peaked at $22K in Q4 2020. 2,041 funds tracked by Wall St. Rank hold TMO as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Thermo Fisher Scientific position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 48 Thermo Fisher Scientific shares in Q1 2021, an estimated $22K.
  • Alpha DNA Investment Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Thermo Fisher Scientific position peaked at $22K in Q4 2020.
  • 2,041 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.